In summary, this work identifies EHMT2 as a KRAS-inducible epigenetic regulator which enables this oncogene to exert its effects on growth and inflammation, even when challenged in the pancreatitis-associated promotion model. The gene discussed is KRAS; the disease is pancreatitis.